THBD and atherosclerosis: Decreased KLF4 activity alters the expression of its downward transcription targets, such as decreased nitric oxide synthase 3 and thrombomodulin, and increased monocyte chemoattractant protein‐1, making the vascular environment prone to inflammation and atherosclerosis.41, 42, 43